Editorial Policies

The Poison® is a scientific journal aimed at the dissemination of knowledge in Clinical Toxicology. It publishes high-quality articles based on international standards and expert review. As it is an open journal published in English, it allows readers worldwide to access the latest breakthroughs in toxicology.

The Poison® is published under peer-to-peer review. Authors will be contacted by email within the 15 (fifteen) days of submitting the manuscript to be informed whether their work has been accepted for revision or rejected. All the original articles, reviews, case reports and others considered relevant by the editors are sent to external reviewers. The identity of the authors and reviewers is kept confidential (double blind).

The process shall be performed by two reviewers selected by the Editorial Board among specialists in each field. They will thoroughly check the manuscript. Should any discrepancies regarding the contents arise, a third reviewer will be invited to participate. They will have a 4-week (four-week) period to examine the manuscript and, based on their report, the Editorial Board may request subsequent amendments. The reviewers’ report shall express whether the article is accepted without amendments, accepted with amendments, or rejected. Their decision is final and shall be informed by the editors to the author within the 3 (three) months after the assessment for section A manuscripts, and 2 (two) months for those of sections B, C and D. The authors shall check their manuscript and approve the final version before publication.

The Poison® is published biannually, in January and June. The contents of this journal are published collectively as part of an issue. Occasionally, articles may be published at other times if the Editorial Board and the author/s so decide (special issue).

The Poison® provides free and immediate access to its contents to any reader, without any subscription fees or registration requirement.

The Poison® adheres to the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors (ICMJE) and to the ethical guidelines established by the Committee on Publication Ethics (COPE).

If the objective is to publish a systematic or narrative review in The Poison®, the author is requested to send an email to editorial@thepoisonjournal.com. The name and surname of the first author, affiliated institution, title of the proposed review and its relevance must be mentioned in the main body. If a favourable response from the Editorial Board is received, the author shall continue with the usual manuscript submission process.

Each person appearing as author of an article published in The Poison® is responsible for having contributed significantly and in an identifiable way to the design, production, analysis and report of the work. To that end, they should consult the Recommendations of the International Committee of Medical Journal Editors (ICMJE) regarding authorship credits.

The Poison® allows only one corresponding author to contact the journal and to receive all the emails related to forms, authorship issues, manuscript files, among others.

The International Committee of Medical Journal Editors (ICMJE) and The Poison® require that researchers register their clinical trials in acceptable clinical trial registries before enrolment of the patients. Articles describing primary outcomes of non-registered trials shall be rejected before peer-review.

In order to be acceptable, a registry must be managed by a not-for-profit organisation, be accessible to the public and include the 20 (twenty) items required by the World Health Organisation (WHO).

The International Committee of Medical Journal Editors (ICMJE) and The Poison® require that researchers submit a data sharing statement and register a data sharing plan when registering a trial.

The Poison® acknowledges that there are many ways of performing statistical analyses and solving problems in this field. Should there be any doubt about the results or specific statistic mistakes, the journal's reviewers/editors may request additional information not included in the material submitted.

When sending their manuscripts, authors should describe and indicate clearly all modification, selective editing and digital improvements performed on any image.

Authors should eliminate any information appearing in photographs or text of the manuscript that may contribute to identifying the patient. Should this be impossible, the presentations must be accompanied by an authorisation of the patient through an Informed Consent. We suggest consulting the latter and the Author Submission Guidelines in The Poison®’s official website.

The authors are responsible for obtaining all the necessary permissions to reproduce any copyrighted material. In that case, the Permission to reproduce material digitally and/or in print shall be attached when submitting the manuscript, as stated in the Author Submission Guidelines available in The Poison®'s web page.

Likewise, the written authorisation of the patients whose photographs are included in the article (see Identifiable Patients section) must be certified.

All the authors should state any conflict of financial interest or any other interest that may bias the results or interpretation of the article. Therefore, together with the manuscript they should attach the Declaration of Interests form available in the Authors section of The Poison®. In turn, journal policies require that no editor has any financial relationship with biomedical companies that may bias their work.

All manuscripts submitted to The Poison® are subject to plagiarism screening as part of the editorial and peer-review process. The journal is committed to maintaining the highest standards of academic integrity and originality. Any form of plagiarism, including self-plagiarism, is strictly prohibited. Should any anomaly arise, the reviewers will take the corresponding measures based on the guidelines suggested in the Flowchart of the Committee on Publication Ethics (COPE).

All articles published in The Poison® are licensed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).

Under this license, authors retain copyright and grant the journal the right of first publication. The articles are freely available to the public, allowing anyone to read, download, copy, distribute, print, search, link to the full texts, or use them for any other lawful purpose, as long as proper credit is given to the original author(s) and source.

The Poison® and its logotypes are trademarks of Panamerican Toxicology® Press. Their use is strictly forbidden for the sale, distribution or advertising of any product or service that may potentially result in confusion, mistake or deception.

The Poison® has advertising space in each issue of the journal, as well as in its official web page, newsletters and social networks. The journal accepts advertising to support its open access model, provided it is relevant to the academic community, honest, and respectful of ethical and scholarly standards. Advertising does not influence editorial decisions, and all ads are clearly separated from editorial content. We reserve the right to reject or remove any advertisement that conflicts with the journal’s values or editorial independence. Acceptance of ads does not imply endorsement by the journal or its editors.

The Poison® requests the payment of a specific amount for the editing service for all the articles accepted for publication. It should be paid within 7 (seven) days after the final acceptance of the manuscript by bank transfer to the journal’s bank account (banking information to be sent by email).

The journal offers APC waivers to papers whose authors are based in countries classified by the World Bank as low-income economies.

For the time being, depending on the section, APCs are as follows:

SECTION A: original articles, short communications, systematic reviews, narrative reviews and mini-reviews USD$ 300

SECTION B: case reports and images in Toxicology USD$ 150

SECTION C: correspondence (letters to the editor and letters of response) FREE OF CHARGE

SECTION D: editorials FREE OF CHARGE

NB Only for Argentina, publication fees are ARS$ 75,000 for section A and ARS$ 50,000 for section B. Sections C and D are free of charge (the same as for foreign authors).

The Poison® follows a long-term digital archiving policy. All articles are securely stored and archived on Zenodo, ensuring they remain accessible and protected over time.

Editorial Policies

Objectives and scopes Peer review Publication frequency Open access policy Publication ethics Presubmission inquiry Authorship Registration of clinical trials Data Sharing Statistics Image manipulation Identifiable patients Permission to reproduce material digitally and/or in print Conflicts of interests Plagiarism detection Licensing Copyright Unauthorised use Advertising policies Article Processing Charge (APC) Archiving policy